Truist Financial Cuts OrthoPediatrics (NASDAQ:KIDS) Price Target to $25.00

OrthoPediatrics (NASDAQ:KIDS) had its target price decreased by Truist Financial from $28.00 to $25.00 in a research report sent to investors on Wednesday,Benzinga reports. Truist Financial currently has a hold rating on the stock.

Several other analysts have also commented on KIDS. Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a report on Friday, November 8th. JMP Securities reaffirmed a “market outperform” rating and set a $50.00 target price on shares of OrthoPediatrics in a report on Friday, September 13th.

OrthoPediatrics Price Performance

NASDAQ:KIDS opened at $22.38 on Wednesday. The firm’s fifty day moving average is $25.26 and its two-hundred day moving average is $28.16. The firm has a market cap of $541.95 million, a price-to-earnings ratio of -18.19 and a beta of 1.14. OrthoPediatrics has a one year low of $21.02 and a one year high of $36.23. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in KIDS. Wellington Management Group LLP raised its position in shares of OrthoPediatrics by 16.2% during the 3rd quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock worth $23,944,000 after purchasing an additional 122,846 shares during the last quarter. State Street Corp raised its holdings in shares of OrthoPediatrics by 1.0% during the third quarter. State Street Corp now owns 417,898 shares of the company’s stock valued at $11,329,000 after acquiring an additional 4,236 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of OrthoPediatrics by 2.1% in the third quarter. Geode Capital Management LLC now owns 391,492 shares of the company’s stock valued at $10,615,000 after acquiring an additional 7,972 shares in the last quarter. Portolan Capital Management LLC boosted its stake in shares of OrthoPediatrics by 66.2% in the third quarter. Portolan Capital Management LLC now owns 308,099 shares of the company’s stock worth $8,353,000 after acquiring an additional 122,770 shares during the last quarter. Finally, Harbor Capital Advisors Inc. increased its position in shares of OrthoPediatrics by 268.1% during the third quarter. Harbor Capital Advisors Inc. now owns 246,860 shares of the company’s stock worth $6,692,000 after purchasing an additional 179,803 shares in the last quarter. 69.05% of the stock is owned by institutional investors and hedge funds.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.